Hormone therapy for acne

Journal of the American Academy of Dermatology

Volumn 62, Issue 3, 2010, Pages 486-488

  Junkins Hopkins, Jacqueline M ^a,b  

^a Based on the dialogue Hormonal therapy for acne between Stephen Stone   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ANTIHYPERTENSIVE AGENT; CORTICOTROPIN RELEASING FACTOR; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FOLLITROPIN; GESTAGEN; GLUCOCORTICOID; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RELEASE INHIBITING FACTOR; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; NEUROPEPTIDE RECEPTOR; ORAL CONTRACEPTIVE AGENT; POTASSIUM; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SPIRONOLACTONE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TOLL LIKE RECEPTOR 2;

ACANTHOSIS NIGRICANS; ACNE; ACNE VULGARIS; ADRENAL TUMOR; ARTICLE; BIRTH CONTROL; BLEEDING; BREAST TENDERNESS; CONGENITAL ADRENAL HYPERPLASIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DRUG INDUCED HEADACHE; DYSPHONIA; ENDOCRINE DISEASE; GENE EXPRESSION; GYNECOMASTIA; HAIR LOSS; HIRSUTISM; HORMONAL THERAPY; HORMONE SYNTHESIS; HUMAN; HYPERKALEMIA; HYPOTENSION; LETHARGY; LIBIDO DISORDER; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; SEBACEOUS GLAND; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID METABOLISM; STRESS; TESTOSTERONE BLOOD LEVEL;

ACNE VULGARIS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS;

EID: 76249104607     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.12.002     Document Type: Article

References (10)

1. George R., Clarke S., and Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg 27 (2008) 188-196
2. Bhambri S., Del Rosso J.Q., and Bhambri A. Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol 8 (2009) 615-618
3. McInturff J.E., and Kim J. The role of toll-like receptors in the pathophysiology of acne. Semin Cutan Med Surg 24 (2005) 73-78
4. Ganceviciene R., Graziene V., Fimmel S., and Zouboulis C.C. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol 160 (2009) 345-352
5. Karrer-Voegeli S., Rey F., Reymond M.J., Meuwly J.Y., Gaillard R.C., and Gomez F. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore) 88 (2009) 32-45
6. Brown J., Farquhar C., Lee O., Toomath R., and Jepson R.G. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2 (2009) CD000194
7. Arowojolu A.O., Gallo M.F., Lopez L.M., Grimes D.A., and Garner S.E. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 3 (2009) CD004425
8. Harper J.C. Should dermatologists prescribe hormonal contraceptives for acne?. Dermatol Ther 22 (2009) 452-457
9. Fenton C., Wellington K., Moen M.D., and Robinson D.M. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs 67 (2007) 1749-1765
10. Mishell Jr. D.R. YAZ and the novel progestin drospirenone. J Reprod Med 53 9 suppl (2008) 721-728